Page 868 - Read Online
P. 868

Page 18 of 28                                      Farber et al. Plast Aesthet Res 2020;7:72  I  http://dx.doi.org/10.20517/2347-9264.2020.152

















































               Figure 15. Orbicularis oculis anatomy. Anatomic drawing of the orbicularis oculi muscle (top) and functional anatomy showing dynamic
               rhytids (bottom)

               The orbicularis oculi, Figure 15, should be injected very superficially to target the muscle and avoid spread
               to the levator palpebrae superioris. These injections serve to obliterate lateral orbital rhytides and to raise
               the lateral brow. Injections should be performed in 1-2 unit aliquots in three to five sites. Patients with very
                                                            [46]
               active muscles may require a second row of injections .
               Complications of upper facial botulinum toxin injections are undesirable but reversible based on the
               temporary effect of treatment. Brow asymmetries or overly peaked brows can be managed with additional,
               judicious injections. Blepharoptosis, however, is not reversible for the duration of treatment effect and can
               only be mitigated with alpha-adrenergic activation of Muller’s muscle to temporarily elevate the eyelid (e.g.,
                                                                                                     [43]
               with apraclonidine drops). Other adverse effects such as swelling, bruising, or redness are self-limiting .
               Lower face and neck
               Botulinum toxin injection in the lower face and neck is more difficult and less reliable than in the upper
               face. Therefore, knowledge of anatomy is critical for using this treatment safely and effectively.

               Treatment of the orbicularis oris softens fine vertical perioral rhytids that occur with animation. It is
               performed by injecting very superficially in two points on the superior and inferior lip at the vermilion
   863   864   865   866   867   868   869   870   871   872   873